Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Decrease of wild-type and precore mutant duck hepatitis B virus replication during lamivudine treatment in white Pekin ducks infected with the viruses.

Journal of hepatology - 1 May 2000

Tomita T, Yokosuka O, Tagawa M, Saisho H, Tamura S, Fukuda I, Omata M

Abstract excerpt

BACKGROUND/AIMS: Lamivudine, an antiviral agent, has been used in the treatment of chronic hepatitis B, but little is known about its effect on intrahepatic replication of hepatitis B virus. We investigated the effect of lamivudine on the replication of wild-type and precore mutant duck hepatitis B virus (DHBV) in the liver and serum of DHBV carrier ducks. METHODS: Chronic carrier ducks with either wild-type or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA, Viral
Share to Ducks

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Lamivudine

Share to Mutation

Share to Reverse Transcriptase Inhibitors

Share to Viral Core Proteins

Share to Virus Replication

Source

Identifiers

PMID: 10845674
DOI: 10.1016/s0168-8278(00)80256-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Decrease of wild-type and precore mutant duck hepatitis B virus replication during lamivudine treatment in white Pekin ducks infected with the viruses.PMID 10845674Read ↗

Half-Life of the Duck Hepatitis B Virus Covalently Closed Circular DNA Pool In Vivo following Inhibition of Viral ReplicationSemantic proximity Read ↗

Duck hepatitis B virus polymerase gene mutants associated with resistance to lamivudine have a decreased replication capacity in vitro and in vivo.Semantic proximity Read ↗

In vitro study of the effects of precore and lamivudine-resistant mutations on hepatitis B virus replication.Semantic proximity Read ↗

Effect of lamivudine therapy on the serum covalently closed-circular (ccc) DNA of chronic hepatitis B infection.Semantic proximity Read ↗

Infection of ducklings with virus particles containing linear double-stranded duck hepatitis B virus DNA: illegitimate replication and reversion.Semantic proximity Read ↗

Enrichment of a precore-minus mutant of duck hepatitis B virus in experimental mixed infections.Semantic proximity Read ↗

Low-dose recombinant interferon therapy in anti-HBe-positive chronic hepatitis B in Asian Indians.Semantic proximity Read ↗

Coinfection study of precore mutant and wild-type hepatitis B-like virus in ducklings.Semantic proximity Read ↗

Lamivudine treatment in maternally transmitted chronic hepatitis B virus infection patients.Semantic proximity Read ↗

Effects of antiviral agents and HBV genotypes on intrahepatic covalently closed circular DNA in HBeAg-positive chronic hepatitis B patients.Semantic proximity Read ↗

Supportive role played by precore and preS2 genomic changes in the establishment of lamivudine-resistant hepatitis B virus.Semantic proximity Read ↗

The effectiveness of lamivudine treatment in cirrhotic patients with HBV precore mutations: a prospective, open-label study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.